Select Page

Introducing HIRO: A New Era in Accelerating Clinical Trials


We are excited to announce a new chapter in our journey!

As we continuously strive to shape the future of healthcare innovation and research, CIDH is transitioning to serve the broader Mass General Brigham system under two new programs: Mass General Brigham Hospital Integrated Research Organization (HIRO) and Mass General Brigham Emerging Technologies and Solutions (MGBETS).

Mass General Brigham’s HIRO is a new initiative that employs data, technology, and operational expertise to accelerate the clinical trial process and improve clinical studies. HIRO focuses on strategic partnerships with industry that provide mutual value, advance MGB’s mission, and support our research community to promote effective treatments and cures for our patients. Our sponsor program leverages MGB’s research data platform and includes access to concierge services and our extensive network of expert clinician-investigators to deliver cost-effective, transformative, patient-centered clinical trials.